The New York City Health Code requires all health care providers to submit a written TB Treatment Plan to the New York City Department of Health & Mental
Hygiene (DOHMH) within one month of starting treatment for newly diagnosed TB patients.
This guide aims to improve case detection, management, and outcomes of children with TB.
The WHO treatment guidelines for drug-resistant TB contains policy recommendations on priority areas in the treatment of drug-resistant TB.
This resource provides access to a variety of tools that enable health professionals to quickly and easily find information about TB in an emergency department setting.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This brochure describes Mycobacterium bovis (bovine tuberculosis) in humans and in cattle.
The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.
This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.
This fact sheet provides an overview of treating TB disease in persons infected with HIV/AIDS.
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2015.
